(Q28139557)

English

Clinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-Genistein in patients with B-lineage lymphoid malignancies

scientific article (publication date: December 1999)

In more languages

Statements

scholarly article

0 references

Clinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-Genistein in patients with B-lineage lymphoid malignancies (English)

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

C L Chen

1

0 references

A Levine

2

0 references

A Rao

3

0 references

K O'Neill

4

0 references

Y Messinger

5

0 references

D E Myers

6

0 references

F Goldman

7

0 references

C Hurvitz

8

0 references

J T Casper

9

0 references

F M Uckun

10

0 references

language of work or name

0 references

publication date

December 1999

0 references

The Journal of Clinical Pharmacology

0 references

39

0 references

12

0 references

1248-55

0 references

Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1177%2F00912709922012051

21 January 2018

Membrane-associated CD19-LYN complex is an endogenous p53-independent and Bc1-2-independent regulator of apoptosis in human B-lineage lymphoma cells

1 reference

https://api.crossref.org/works/10.1177%2F00912709922012051

21 January 2018

Large scale manufacturing of B43(anti-CD19)-genistein for clinical trials in leukemia and lymphoma

1 reference

https://api.crossref.org/works/10.1177%2F00912709922012051

21 January 2018

In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022.

1 reference

https://api.crossref.org/works/10.1177%2F00912709922012051

21 January 2018

Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1177%2F00912709922012051

21 January 2018

Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases

1 reference

https://api.crossref.org/works/10.1177%2F00912709922012051

21 January 2018

In vivo toxicity and pharmacokinetic features of B43(Anti-CD19)-Genistein immunoconjugate

1 reference

https://api.crossref.org/works/10.1177%2F00912709922012051

21 January 2018

Pharmacokinetics and biologic activity of the novel mast cell inhibitor, 4-(3-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline in mice

1 reference

https://api.crossref.org/works/10.1177%2F00912709922012051

21 January 2018

Identifiers

10.1177/00912709922012051

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28139557&oldid=1695045831"